Drawing for CLARISURE

USPTO serial 77049015

CLARISURE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SERVANCE, RENEE L
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CLARISURE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David J. Davis

David J. Davis Baker & McKenzie LLP130 E Randolph StreetSuite 3500Chicago, IL 60601-6314

Goods and services

ClassDescriptionStatusFirst use
005Diagnostic reagents, assays and kits for clinical and medical laboratory use, namely, for detecting genetic disorders and for detecting hematological/oncological disorders; diagnostic reagents and assays for the treatment, monitoring and diagnosis of mental retardation and hematological/oncology disorders; diagnostic kits consisting primarily of diagnostic assays, specimen holders, diagnostic preparation agents, and specimen preparation agents for use in diagnosing, treating and monitoring of genetic disorders and hematological/oncological disorders; diagnostic kits consisting primarily of diagnostic assays, specimen holders, diagnostic preparation agents, and specimen preparation agents for genetic disorders and hematological/oncological disorder testingABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2008MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Oct 14, 2008ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Oct 14, 2008OP.TOPPOSITION TERMINATED NO. 999999—
Oct 14, 2008OP.SOPPOSITION SUSTAINED NO. 999999—
Jun 24, 2008OP.IOPPOSITION INSTITUTED NO. 999999—
Jan 8, 2008ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Dec 25, 2007PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 5, 2007NPUBNOTICE OF PUBLICATION—
Nov 16, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 5, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 11, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 11, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 3, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2007CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Apr 9, 2007ALIEASSIGNED TO LIE—
Apr 9, 2007CEAPEXAMINER'S AMENDMENT/PRIORITY ACTION MAILED—
Apr 9, 2007CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Mar 22, 2007DOCKASSIGNED TO EXAMINER—
Nov 29, 2006MPMKNOTICE OF PSEUDO MARK MAILED—
Nov 28, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance